Literature DB >> 1851781

Pressure to treat and pressure to cost: a review of cost-effectiveness analysis.

A Fletcher.   

Abstract

Keywords:  Health Care and Public Health

Mesh：

Year:  1991        PMID： 1851781     DOI： 10.1097/00004872-199103000-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  6 in total

Review 1.  Pharmacoeconomics of hypertension management: the place of combination therapy.

Authors:  E Ambrosioni
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Quality of life as an outcome measure.

Authors:  C J Bulpitt
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

3.  Pharmacoeconomic evaluation of risk factors for cardiovascular disease: an epidemiological perspective.

Authors:  A E Fletcher; C J Bulpitt
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

Review 4.  Quality-of-life instruments in hypertension.

Authors:  C J Bulpitt; A E Fletcher
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

Review 5.  Defining the patient group for cost-effective withdrawal of antihypertensive therapy.

Authors:  L R Krakoff; S Wassertheil-Smoller
Journal:  Pharmacoeconomics       Date:  1995-03       Impact factor: 4.981

Review 6.  Economics of hypertension control. World Hypertension League.

Authors: 
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.